Business Context and Reporting Period
This Form 8-K filing by eHealth, Inc. (the "Company") reports the completion of an asset acquisition on January 22, 2018. The Company acquired all outstanding membership interests of Wealth, Health and Life Advisors, LLC (d/b/a GoMedigap), a Texas limited liability company specializing in Medicare supplement insurance.
Key Financial Metrics and Transaction Details
The acquisition consideration structure is as follows:
- Closing Consideration: Approximately $14.83 million in cash (calculated as $15 million less $171,250 in purchase price adjustments) and approximately 294,637 shares of Company common stock.
- Earnout Consideration: Potential aggregate value of approximately $30 million, contingent on achieving specific milestones in 2018 and 2019. This consists of approximately $20 million in cash and approximately 589,275 shares of Company common stock.
- Adjustments: The purchase price is subject to customary working capital adjustments based on the estimated net working capital at closing.
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity metrics for the Company or the acquired entity within this document.
Material Changes and Financial Reporting
The primary material change is the addition of GoMedigap as a subsidiary. Regarding financial reporting requirements:
- Historical Financials: The Company requested and received SEC relief from filing audited historical financial statements for GoMedigap, deeming them immaterial to shareholders.
- Disclosure Method: Instead of immediate audited statements, the Company will provide disclosure pursuant to ASC 805-10-50-2 in a subsequent event footnote in its Form 10-K for the year ended December 31, 2017.
- Pro Forma Information: Pro forma financial information is not included in this filing but will be provided in the Form 10-K or filed separately within 71 calendar days of the required filing date.
Outlook, Risks, and Contingencies
Contingencies: A significant portion of the total consideration (approximately $30 million) is contingent upon the achievement of performance milestones in 2018 and 2019. Payment of the earnout is subject to the terms of the Purchase Agreement.
Management Commentary: The filing references a press release issued on January 16, 2018, for further details and forward-looking statements, noting that the press release should be read in conjunction with the note regarding forward-looking statements.
Risks: The filing does not explicitly list new risks beyond the standard contingencies associated with earnout payments and working capital adjustments.
Investor Verification Checklist
- Verify the final working capital adjustment amount to determine the exact cash consideration paid at closing.
- Review the specific performance milestones required to trigger the $30 million earnout payment in the full Purchase Agreement.
- Monitor the upcoming Form 10-K for the ASC 805-10-50-2 disclosure and pro forma financial information regarding the impact of the acquisition.
- Confirm the valuation of the common stock issued at the time of closing versus the current market price to assess the total equity dilution.